Additionally, metformin activates adenosine monophosphate-activated protein kinase (AMPK), decreases the mammalian target of rapamycin (mTOR) and S6 kinase activation, and decreases mRNA translation [104] in breast cancer. The gene discussed is MTOR; the disease is breast carcinoma.